NRXP is the official Nasdaq stock exchange ticker symbol for NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical enterprise. The company focuses on discovering, developing, and commercializing novel therapeutics targeting central nervous system disorders, suicidal depression, and severe respiratory diseases, utilizing proprietary drug formulations and advancing regulatory pathways toward commercialization.